Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Production & Manufacturing
OTC
Return to: PBR Home | Production & Manufacturing | OTC

OTC

Ember Therapeutics to buy Dermasilk Brands Ember Therapeutics has agreed to acquire Dermasilk Brands, a commercially available over-the-counter beauty product portfolio encompassing fourteen different products.
Production & Manufacturing > OTC > News
Crescita Therapeutics acquires INTEGA Skin Sciences Crescita Therapeutics has acquired INTEGA Skin Sciences, a Montreal-based dermatology company which develops, manufactures, sells and markets science-based quality skin care products.
Production & Manufacturing > OTC > News Teva to buy Allergan's Anda distribution business for $500m By PBR Staff Writer
Teva Pharmaceutical Industries has agreed to acquire Allergan's Anda distribution business for $500m.
Production & Manufacturing > OTC > News
See more OTC news

Latest OTC News and Insight

View all OTC news or find news targeted to your interests
Espada acquires GlyDerm line of skin care products from Lautus Pharmaceuticals
Espada Dermatology has acquired the GlyDerm line of skin care products from Lautus Pharmaceuticals.
Production & Manufacturing > OTC > News
Moberg Pharma completes acquisition of US OTC brands from Prestige Brands
On 30 June, Moberg Pharma announced the acquisition of three Over-The-Counter brands in the U.S. from Prestige Brands. The acquisition has now been completed. The purchase price amounted to $40 million.
Production & Manufacturing > OTC > News
Galderma secures FDA approval for Differin Gel as OTC treatment for acne
Galderma's U.S. affiliate, Galderma Laboratories received approval from the U.S. Food and Drug Administration (FDA) for Differin Gel (adapalene gel 0.1%) as an over-the-counter (OTC) treatment for acne.
Production & Manufacturing > OTC > News
Moberg Pharma agrees to acquire three US OTC brands from Prestige Brands
Moberg Pharma has signed an agreement to acquire New Skin, Fiber Choice and PediaCare, three well-established Over-The-Counter brands in the U.S. from Prestige Brands.
Production & Manufacturing > OTC > News
VANC Pharmaceuticals signs definitive deal for filing two ANDS with exclusive marketing rights to Canada
VANC Pharmaceuticals, a pharmaceutical company focused on the Canadian generic drug and over-the-counter market, has entered into a definitive agreement for filing two abbreviated new drug submissions (ANDS) with exclusive marketing rights to Canada from an unnamed, manufacturer.
Production & Manufacturing > OTC > News
FDA warns OTC antacid products containing Aspirin may cause severe bleeding
By PBR Staff Writer
The US Food and Drug Administration (FDA) is warning consumers about the risk of severe bleeding when using over-the-counter (OTC) aspirin-containing antacid products.
Production & Manufacturing > OTC > News
Dr. Reddy’s Laboratories acquires six OTC brands
Dr. Reddy’s Laboratories has acquired a portfolio of over-the-counter (OTC) brands in the cough-and-cold, pain, and dermatology categories.
Production & Manufacturing > OTC > News
Mylan to buy Renaissance's dermatology business in $1bn deal
By PBR Staff Writer
Mylan has agreed to acquire the non-sterile, topicals-focused specialty and generics business of Renaissance Acquisition Holdings for about $1bn.
Production & Manufacturing > OTC > News
Perrigo receives final FDA approval for generic version of Valeant's BenzaClin Pump Topical Gel
Perrigo has received final US Food and Drug Administration (FDA) approval for the generic version of Valeant Pharmaceutical International's BenzaClin Pump Topical Gel.
Production & Manufacturing > OTC > News
Health Canada approves Vanc Pharmaceuticals' Cortivera-H product for minor skin irritations
Health Canada has approved Vanc Pharmaceuticals' Cortivera-H, a premium topical product for minor skin irritations.
Production & Manufacturing > OTC > News
View all OTC news or find news targeted to your interests